Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Nutra Pharma Completes First Royalty Payment to Nanologix for Test Kit Technology
April 11th, 2007
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced that it has completed its first royalty payment to NanoLogix, Inc (Other OTC: NNLX) for the licensing rights to the technology used in the Designer Diagnostics test kits. Designer Diagnostics is the wholly-owned medical device subsidiary of Nutra Pharma. The Company currently owns 11 patents and has licensed an additional 18 patents from NanoLogix that protect the technology surrounding the test kits. "Not only does this royalty payment secure our licensing rights to the test kit technology, but it also confirms our...
Source: Medical Patent Law Weekly (2007-04-11)
|
